<VariationArchive VariationID="973871" VariationName="NM_000213.5(ITGB4):c.5091del (p.Glu1698fs)" VariationType="Deletion" Accession="VCV000973871" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2020-08-01" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="962192" VariationID="973871">
      <GeneList>
        <Gene Symbol="GALK1" FullName="galactokinase 1" GeneID="2584" HGNC_ID="HGNC:4118" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75751469" stop="75765192" display_start="75751469" display_stop="75765192" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73754017" stop="73761279" display_start="73754017" display_stop="73761279" Strand="-" />
          </Location>
          <OMIM>604313</OMIM>
        </Gene>
        <Gene Symbol="ITGB4" FullName="integrin subunit beta 4" GeneID="3691" HGNC_ID="HGNC:6158" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75721459" stop="75757818" display_start="75721459" display_stop="75757818" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73717515" stop="73753898" display_start="73717515" display_stop="73753898" Strand="+" />
          </Location>
          <OMIM>147557</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000213.5(ITGB4):c.5091del (p.Glu1698fs)</Name>
      <CanonicalSPDI>NC_000017.11:75756976:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75756977" stop="75756977" display_start="75756977" display_stop="75756977" variantLength="1" positionVCF="75756976" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73753058" stop="73753058" display_start="73753058" display_stop="73753058" variantLength="1" positionVCF="73753057" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E1628fs</ProteinChange>
      <ProteinChange>E1681fs</ProteinChange>
      <ProteinChange>E1698fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.73753061del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.73753061del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.75756980del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.75756980del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007372.2" sequenceAccession="NG_007372" sequenceVersion="2" change="g.40523del">
            <Expression>NG_007372.2:g.40523del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008079.2" sequenceAccession="NG_008079" sequenceVersion="2" change="g.13223del">
            <Expression>NG_008079.2:g.13223del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000213.5" sequenceAccession="NM_000213" sequenceVersion="5" change="c.5091del" MANESelect="true">
            <Expression>NM_000213.5:c.5091del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000204.3" sequenceAccession="NP_000204" sequenceVersion="3" change="p.Glu1698fs">
            <Expression>NP_000204.3:p.Glu1698fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005619.1" sequenceAccession="NM_001005619" sequenceVersion="1" change="c.5040del">
            <Expression>NM_001005619.1:c.5040del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005619.1" sequenceAccession="NP_001005619" sequenceVersion="1" change="p.Glu1681fs">
            <Expression>NP_001005619.1:p.Glu1681fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005731.3" sequenceAccession="NM_001005731" sequenceVersion="3" change="c.4881del">
            <Expression>NM_001005731.3:c.4881del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005731.1" sequenceAccession="NP_001005731" sequenceVersion="1" change="p.Glu1628fs">
            <Expression>NP_001005731.1:p.Glu1628fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321123.2" sequenceAccession="NM_001321123" sequenceVersion="2" change="c.4881del">
            <Expression>NM_001321123.2:c.4881del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308052.1" sequenceAccession="NP_001308052" sequenceVersion="1" change="p.Glu1628fs">
            <Expression>NP_001308052.1:p.Glu1628fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001381985.1" sequenceAccession="NM_001381985" sequenceVersion="1" change="c.*22+1057del">
            <Expression>NM_001381985.1:c.*22+1057del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1430" sequenceAccession="LRG_1430">
            <Expression>LRG_1430:g.13223del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1157557804" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000213.5(ITGB4):c.5091del (p.Glu1698fs) AND Junctional epidermolysis bullosa with pyloric atresia" Accession="RCV001250537" Version="10">
        <ClassifiedConditionList TraitSetID="4073">
          <ClassifiedCondition DB="MedGen" ID="C5676875">Junctional epidermolysis bullosa with pyloric atresia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000213.5(ITGB4):c.5091del (p.Glu1698fs) AND multiple conditions" Accession="RCV002480861" Version="8">
        <ClassifiedConditionList TraitSetID="81981">
          <ClassifiedCondition DB="MedGen" ID="C5676956">Epidermolysis bullosa, junctional 5A, intermediate</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5676875">Junctional epidermolysis bullosa with pyloric atresia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000213.5(ITGB4):c.5091del (p.Glu1698fs) AND not provided" Accession="RCV003770296" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-09" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2020-08-01" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11328943</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18955862</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23496044</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9792864</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9892956</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301304</ID>
          <ID Source="BookShelf">NBK1125</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81981" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="2092" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EB-PA-ACC</ElementValue>
                <XRef Type="MIM" ID="226730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa with pyloric atresia</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+with+Pyloric+Atresia/2585" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carmi syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aplasia cutis congenita with gastrointestinal atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, with pyloric atresia and aplasia cutis congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa junctionalis with pyloric atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa with pyloric atresia</ElementValue>
                <XRef ID="MONDO:0009183" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA</ElementValue>
                <XRef Type="MIM" ID="226730" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0006" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EB-PA</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PA-JEB</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9694" />
                <XRef ID="9694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; and ureteral and renal anomalies (dysplastic/multicystic kidney, hydronephrosis/hydroureter, ureterocele, duplicated renal collecting system, absent bladder). The course of EB-PA is usually severe and often lethal in the neonatal period. Most affected children succumb as neonates; those who survive may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Additional features shared by EB-PA and the other major forms of EB include congenital localized absence of skin (aplasia cutis congenita) affecting the extremities and/or head, milia, nail dystrophy, scarring alopecia, hypotrichosis, contractures, and dilated cardiomyopathy.</Attribute>
                <XRef ID="NBK1157" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301336</ID>
                <ID Source="BookShelf">NBK1157</ID>
              </Citation>
              <XRef ID="79403" DB="Orphanet" />
              <XRef ID="C5676875" DB="MedGen" />
              <XRef ID="MONDO:0009183" DB="MONDO" />
              <XRef Type="MIM" ID="226730" DB="OMIM" />
            </Trait>
            <Trait ID="62006" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, GENERALIZED INTERMEDIATE</ElementValue>
                <XRef Type="MIM" ID="619816" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, NON-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="619816" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa, junctional 5A, intermediate</ElementValue>
                <XRef ID="MONDO:0030768" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JEB5A</ElementValue>
                <XRef Type="MIM" ID="619816" DB="OMIM" />
              </Symbol>
              <XRef ID="C5676956" DB="MedGen" />
              <XRef ID="MONDO:0030768" DB="MONDO" />
              <XRef Type="MIM" ID="619816" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4073" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2092" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EB-PA-ACC</ElementValue>
                <XRef Type="MIM" ID="226730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa with pyloric atresia</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+with+Pyloric+Atresia/2585" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carmi syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aplasia cutis congenita with gastrointestinal atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, with pyloric atresia and aplasia cutis congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa junctionalis with pyloric atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa with pyloric atresia</ElementValue>
                <XRef ID="MONDO:0009183" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA</ElementValue>
                <XRef Type="MIM" ID="226730" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="147557.0006" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EB-PA</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PA-JEB</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9694" />
                <XRef ID="9694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; and ureteral and renal anomalies (dysplastic/multicystic kidney, hydronephrosis/hydroureter, ureterocele, duplicated renal collecting system, absent bladder). The course of EB-PA is usually severe and often lethal in the neonatal period. Most affected children succumb as neonates; those who survive may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Additional features shared by EB-PA and the other major forms of EB include congenital localized absence of skin (aplasia cutis congenita) affecting the extremities and/or head, milia, nail dystrophy, scarring alopecia, hypotrichosis, contractures, and dilated cardiomyopathy.</Attribute>
                <XRef ID="NBK1157" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301336</ID>
                <ID Source="BookShelf">NBK1157</ID>
              </Citation>
              <XRef ID="79403" DB="Orphanet" />
              <XRef ID="C5676875" DB="MedGen" />
              <XRef ID="MONDO:0009183" DB="MONDO" />
              <XRef Type="MIM" ID="226730" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2812662" SubmissionDate="2020-05-28" DateLastUpdated="2020-08-01" DateCreated="2020-08-01">
        <ClinVarSubmissionID localKey="NM_000213.4:c.5088delC|OMIM:226730" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001425350" DateUpdated="2020-08-01" DateCreated="2020-08-01" Type="SCV" Version="1" SubmitterName="Johns Hopkins Genomics, Johns Hopkins University" OrgID="506823" OrganizationCategory="laboratory" OrgAbbreviation="JHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11328943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18955862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301304</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23496044</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9792864</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9892956</ID>
          </Citation>
          <Comment>ITGB4 c.5091delC is rare (&lt;0.1%) in a large population dataset (gnomAD: 1/249182 total alleles; 0.0004%; no homozygotes) and has not been reported in the literature, to our knowledge. This frameshift variant results in a premature stop codon in exon 38 of 40 likely leading to nonsense-mediated decay and lack of protein production. We consider c.5091delC to be likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000213.4:c.5088delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226730" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7512543</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5449620" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001005731.3:c.4881del|OMIM:226730;619816" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002797993" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001005731.3:c.4881del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226730" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619816" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8598970" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="13127871|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004644554" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11328943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu1628Argfs*4) in the ITGB4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ITGB4 are known to be pathogenic (PMID: 11328943, 16473856). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with ITGB4-related conditions. ClinVar contains an entry for this variant (Variation ID: 973871). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.73753058del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8598970" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449620" TraitType="Disease" MappingType="XRef" MappingValue="619816" MappingRef="OMIM">
        <MedGen CUI="C5676956" Name="Epidermolysis bullosa, junctional 5A, intermediate" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2812662" TraitType="Disease" MappingType="XRef" MappingValue="226730" MappingRef="OMIM">
        <MedGen CUI="C5676875" Name="Junctional epidermolysis bullosa with pyloric atresia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449620" TraitType="Disease" MappingType="XRef" MappingValue="226730" MappingRef="OMIM">
        <MedGen CUI="C5676875" Name="Junctional epidermolysis bullosa with pyloric atresia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

